Divalproex Sodium Capsule, Delayed Release
Product Images NDC 62332-821

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 62332-821). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Divalproex-figr1.jpg (Divalproex Figr1)

Divalproex-figr1.jpg (Divalproex Figr1)
This text is a tabulated comparison showing the reduction in CPS Rate for two different groups: Divalproex Sodium and Placebo. The table shows the percentage of patients with improvement, no change, or worsening. The reduction in CPS Rate ranges from -100% to 100%, with markings for different percentage intervals.*
FDA Label Image

Divalproex-figr2.jpg (Divalproex Figr2)

FDA Label Image

Divalproex-ifu-p2.jpg (Divalproex Ifu P2)

FDA Label Image

Divalproex-ifu-p3.jpg (Divalproex Ifu P3)

FDA Label Image

Divalproex-ifu-p4.jpg (Divalproex Ifu P4)

FDA Label Image

Divalproex-ifu-p5.jpg (Divalproex Ifu P5)

FDA Label Image

100 Sprinkle Capsules (Divalproex mg 125)

FDA Label Image

Divalproex-structure.jpg (Divalproex Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.